We’re a different kind of global biopharmaceutical company.
Discover more
Teva is focused on growth by developing new collaborations to expand its reach and promote innovation. Building on its strong generics portfolio, the company is enhancing production of innovative medicines and biosimilars to better serve patients and health communities.
Artificial Intelligence and advanced analytics hold significant promise for transforming healthcare. We spoke with Teva employees who are actively leveraging these technologies
Amalia Adler-Waxman, SVP Head of Sustainability at Teva, indicates the key trends in this area.